Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia

Author(s):  
Yi Tang ◽  
Ruo-li Wang ◽  
Dan-dan Ruan ◽  
Xin Chen ◽  
Yan-feng Zhou ◽  
...  
2021 ◽  
Vol 8 ◽  
Author(s):  
Zhunan Xu ◽  
Zhongbao Zhou ◽  
Yingmei Mu ◽  
Tong Cai ◽  
Zhenli Gao ◽  
...  

Background: Prostatic artery embolization (PAE) in the treatment of benign prostatic hyperplasia (BPH) has been introduced into clinical practice, but conclusive evidence of efficacy and safety has been lacking.Objective: To compare the efficacy and safety of prostatic artery embolization (PAE) vs. transurethral resection of prostate (TURP), we performed a meta-analysis of clinical trials.Methods: We searched randomized controlled trials (RCTs) from Pubmed, Embase, Wanfang, and CNKI from January 2000 to December 2020 and used RevMan 5.0 to analyze the data after five RCTs were included.Results: The reducing of prostate volume (PV) [Median mean (MD) 14.87; 95% confidence interval (CI) 7.52–22.22; P < 0.0001] and the increasing of maximum flow rate in free uroflowmetry (Qmax) (MD 3.73; 95% CI 0.19–7.27; P = 0.004) were more obvious in TURP than in PAE; however, the rate of lower sexual dysfunction [odds ratio (OR) 0.12; 95% CI 0.05–0.30; P < 0.00001] was lower in PAE compared with TURP. Meanwhile, no conspicuous difference in International Prostate Symptoms Score (IPSS) score (MD 1.42; 95% CI −0.92 to 3.75; P = 0.23), quality of life (Qol) score (MD 0.21; 95% CI −0.31 to 0.73; P = 0.43), post void residual (PVR) (MD 21.16; 95% CI −5.58 to 47.89; P = 0.12), prostate-specific antigen (PSA) (MD 0.56; 95% CI −0.15 to 1.27; P = 0.12), and complications (OR 0.90; 95% CI 0.20–4.05; P = 0.89) between PAE and TURP group was shown.Conclusion: PAE may replace TURP as an alternative treatment for Benign prostatic hyperplasia (BPH) patients who do not want to have surgery or with operational contraindications.


2020 ◽  
Vol 8 (3) ◽  
pp. 130-133
Author(s):  
Ahmed Radwan ◽  
Ahmed Farouk ◽  
Ahmed Higazy ◽  
Younan R. Samir ◽  
Ahmed M. Tawfeek ◽  
...  

2019 ◽  
Vol 18 (1) ◽  
pp. e1494-e1495
Author(s):  
P.J. Giral Villalta ◽  
J.F. Aguilar Guevara ◽  
G. López Ubillos ◽  
S. Lacarra Fernández ◽  
A. Zabalo San Juan ◽  
...  

2018 ◽  
Vol Volume 10 ◽  
pp. 17-22 ◽  
Author(s):  
Saturnino Napal Lecumberri ◽  
Iñigo Insausti Gorbea ◽  
Ana Sáez de Ocariz García ◽  
Saioa Solchaga Álvarez ◽  
José Luis Cebrián Lostal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document